Objective-To examine by Holter electrocardiographic monitoring the effect of abruptly stopping nitrate treatment in patients with stable angina pectoris.
Patients-12 men with confirmed ischaemic heart disease and stable exertional class 3 angina (Canadian). All had episodes of horizontal or down sloping ST segment depression during 24 hour electrocardiographic monitoring. All were nitrate responders. Design-Each patient was given isosorbide dinitrate (10-30 mg four times a day) and placebo (four times a day) for three days in a randomised crossover trial. There was a washout period of 3-5 days between the two treatment periods. Holter monitoring was performed on the third day of isosorbide dinitrate and placebo administration and on the first day of their withdrawal. Results-When treatment with isosorbide dinitrate was stopped there was a significant increase in the total number and duration of painless episodes of myocardial ischaemia. During placebo and isosorbide dinitrate administration 8 patients had episodes of painless myocardial ischaemia whereas after isosorbide dinitrate cessation they were recorded in all 12 patients. Episodes of silent myocardial ischaemia at rest appeared in 4 patients after isosorbide dinitrate withdrawal. Conclusion-Abrupt cessation of shortterm continuous nitrate treatment in patients with severe angina may cause a rebound increase in myocardial ischaemia which is predominantly silent.
(Heart 1996;75:447-450) The possibility of a nitrate withdrawal phenomenon was also revealed in several studies of intermittent treatment with transdermal glyceryl trinitrate. DeMots et al described the appearance of or increased frequency of nocturnal anginal attacks in nine of 206 patients receiving intermittent treatrnent with transdermal glyceryl trinitrate.'0 They described the so-called "time-zero" effect which was manifested by the ability of a placebo group to exercise longer to the development of angina than an active treatment group at the end of the drug-free interval. Ferratini et al observed an increase in the number of angina attacks at night after the removal of transdermal glyceryl trinitrate in six out of 10 patients.1' Freedman et al described a tendency towards an increase in the duration of ischaemia during the nitrate-free interval in patients receiving transdermal glyceryl trinitrate intermittently for a week. 12 Byer and Fung recently performed a special experimental study to establish the mechanisms of nitrate rebound and found that abrupt (but not graded) withdrawal of a 90 minute intravenous infusion of glyceryl trinitrate caused a rebound increase left ventricular end diastolic pressure. They concluded that rebound depends mainly on the degree of neurohormonal activation during drug administration and the rate of its disappearance after administration stops. ' There is another explanation for the size of the rebound after nitrate withdrawal that was found in the present study. Most patients included in the studies which did not find any signs of nitrate withdrawal phenomenon had moderately severe angina and/or were being treated with concomitant antianginal agents (p adrenoblockers or calcium antagonists). [19] [20] [21] This was not the case in our study where all patients had class 3 angina, lower exercise tolerance, and frequent episodes of angina; no patient received any additional antianginal treatment during the study. It can be concluded, therefore, that the withdrawal phenomenon is far more likely to occur in patients with advanced ischaemic heart disease and severe angina pectoris: it may not be a problem in patients with less severe angina.
There could be a relation between the rebound phenomenon and the development of tolerance to nitrates, although this is not yet established."3 We can speculate that because the effect of isosorbide dinitrate on ischaemic episodes was slight tolerance to nitrates had developed in our patients. However, exercise tests showed a significant increase in exercise duration two hours after drug administration so perhaps tolerance was only partial.
It is arguable whether these relatively minor changes in ischaemic profile after the end of nitrate treatment are of any clinical significance. However, many believe that silent myocardial ischaemia is an important influence on prognosis22 23 and that treatment should aim at eliminating or decreasing painless ischaemic episodes as well as painful ones.24 CLINICAL 
IMPLICATIONS
Nitrates are abruptly stopped in different situations-for example, during physician-initiated drug withdrawal because tolerance or side effects have developed or when a patient does not comply with the treatment regimen. It may also occur when nitrates are prescribed intermittently. The results of our study suggests that the dose should be tapered if continuous treatment with nitrates has to be stopped. We recommend that cautious attention is paid to all forms of intermittent nitrate treatment in patients with severe angina pectoris.
